Going green Next Generation Pharmaceutical (Europe)              Collaboration and innovation Next Generation Pharmaceutical (Europe)              Pushing the frontiers of disease prevention Next Generation Pharmaceutical (Europe)              The power of perception Next Generation Pharmaceutical (Europe)              Supply chain optimisation Next Generation Pharmaceutical (Europe)              Translational medicine paradigm: hip or hype? Next Generation Pharmaceutical (US)              The evolution of drug safety Next Generation Pharmaceutical (US)              Investigating cell death resistance in tumor cells Next Generation Pharmaceutical (US)              A culture of engagement and inclusion Next Generation Pharmaceutical (US)              Leading Lilly forward Next Generation Pharmaceutical (US)             

Contributors

John Lechleiter
John Lechleiter
COO, Eli Lilly
Leading Lilly forward

Ken Murtha
Ken Murtha
Regional VP Supply for the Americas, AstraZeneca
The importance of operations

Jill Robinson
Jill Robinson
VP of Global Safety Surveillance, Wyeth Research
The new risk management paradigm

Mary Ellen Turner
Mary Ellen Turner
VP Risk Management, Wyeth Research
The new risk management paradigm

Dr. Andreas Busch
Dr. Andreas Busch
Head of Global Drug Discovery, Bayer Schering Pharma
Big in Germany

Tracy Lefteroff
Tracy Lefteroff
Price Waterhouse Coopers
Looking to the future

Latest Webcasts

Use this link to access our webcast archive

Best Practices in Grid Computing / Univa UD
Date: 31 Jan 2008
Duration: 22min24s

View now


Innovadyne Technologies Inc.
Date: 3 May 2007

View now


The Need for An Enterprise Compliance Platform for Life Sciences
Date: 4 Dec 2006

Summary: EMC understands the unique challenges to Life Science companies. To learn more about the EMC Enterprise Compliance Platorm for Life Sciences please view our webinar, "The Need for An Enterprise Compliance Platform for Life Sciences"

View now


Enabling Multiplex Real-time PCR Technology - A novel approach to overcome limitations in quantitative, multiplex PCR
Speaker: Dr. Andreas Missel

Summary: Multiplex, real-time PCR is a powerful tool for gene expression analysis, viral load monitoring, genotyping, and many other applications. The ability to amplify and detect several genomic DNA, cDNA, or RNA targets in the same reaction vessel offers many benefits. In this QIAGEN webinar, “Enabling Multiplex Real-time PCR Technology – A novel approach to overcome limitations in quantitative, multiplex PCR”, Dr. Andreas Missel will demonstrates how to overcome the optimization challenges typically associated with this technology.

View now


The Publication COVER: Next Generation Pharmaceutical 12

See More >>

Sponsors

Vendor Perspectives

Article
The iuvo Microconduit Array (MCA)
BellBrook Labs
More >>

Article
The Top 3 Grid Application Areas for Pharma R&D: Drug Discovery, Clinical Analysis and Data Management
Univa UD
More >>

Article
4plex, real-time one-step RT-PCR without optimization
QIAGEN
More >>

Article
View from 37,000 feet – weathering change in the Pharmaceutical Industry
Triligent International
More >>

Article
Moving beyond rote case reporting: demonstrating a believable commitment to patient safety
ArisGlobal LLC
More >>

Article
Coping successfully with changing regulations in Experimental Clinical Pharmacology (Phase I)
Simbec Research Ltd
More >>

The Leader